These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 20180658)

  • 1. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
    Maghsoodi M; Esfahani M
    Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
    Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
    Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
    Ingkatawornwong S; Kaewnopparat N; Tantishaiyakul V
    Pharmazie; 2001 Mar; 56(3):227-30. PubMed ID: 11265589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A; Bekmezci S
    Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
    Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
    Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication and in vivo evaluation of highly pH-responsive acrylic microparticles for targeted gastrointestinal delivery.
    Kendall RA; Alhnan MA; Nilkumhang S; Murdan S; Basit AW
    Eur J Pharm Sci; 2009 Jun; 37(3-4):284-90. PubMed ID: 19491017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit l100.
    Maghsoodi M
    AAPS PharmSciTech; 2009; 10(1):120-8. PubMed ID: 19184624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of selected formulation variables on the preparation of enzyme-entrapped Eudragit S100 microspheres.
    Rawat M; Saraf S; Saraf S
    AAPS PharmSciTech; 2007 Dec; 8(4):E116. PubMed ID: 18181537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation and characterization of solid dispersions of piroxicam and polyvinylpyrrolidone using spray drying and precipitation with compressed antisolvent.
    Wu K; Li J; Wang W; Winstead DA
    J Pharm Sci; 2009 Jul; 98(7):2422-31. PubMed ID: 18972575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
    Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique.
    Chauhan B; Shimpi S; Paradkar A
    Eur J Pharm Sci; 2005 Oct; 26(2):219-30. PubMed ID: 16087324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.